AIM
AIM ImmunoTech
36 hedge funds and large institutions have $4.68M invested in AIM ImmunoTech in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
36
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$29K | |
| 2 | +$24K | |
| 3 | +$16K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$15K |
| 5 |
Jane Street
New York
|
+$8K |
Top Sellers
| 1 | -$307K | |
| 2 | -$240K | |
| 3 | -$89K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$16K |
| 5 |
Millennium Management
New York
|
-$14K |